Appeal of the Japanese Market

Our publication is referenced in Lacerta Bio’s blog on the Japanese Market. Have We Forgotten About Japan?  


Attending BIO International Conference in Philadelphia

We will be attending the BIO International conference once again, this time in Philadelphia. Join us if you’re also around!


Pricing Pharmaceuticals in Japan

Recently published an article on pricing pharmaceuticals in Japan on IPI Media website.  Please read more on the link below. Pricing Pharmaceuticals in Japan


Attending BioEurope again!

e-Projection will back in Europe for the exciting BioEurope conference again! This time we will be in the beautiful city of Copenhagen from November 5-7. We will be meeting with brand new faces as well as catching up with others we have worked in the past. If you are going to be in the city […]


Effects of Quitting Alcohol: Personal Experience

Fifteen years ago, I decided to quit one habit which I have kept for more than a decade, smoking. I do not remember if there were any immediate health effects felt from doing so, but perhaps at least the good thing was that I have not experienced any negative effects from smoking tobacco. My father […]


Attractive Opportunities in Japanese Pharmaceuticals: A Closer Look

At a certain point in its corporate life cycle, biotech companies start to consider local deals; that is, licensing their product’s rights in certain geographies to local pharmaceutical companies. The primary reason of doing so is cash. Biotechs are always running lean, and it is almost intentionally kept that way. But time to time, it […]


Attending BioPharm America and NLS Days this year again

This September, e-Projection will be planning for another world tour for two consecutive years. BioPharm America: September 5–6, 2018, Hynes Convention Center, Boston, MA Nordic Life Science Days: September  10-12, 2018, September, Stockholm Waterfront Congress Center, Nils Ericsons Plan 4, Stockholm It will be an exiting two weeks both in the US and in Europe. Come join […]


Presentation at the Japan Pharma & Governance Tour at UBS Securities

I was asked to join and present at a panel discussion organised by UBS Securities with the fund managers, to talk about the Japanese pharma market in general and also about the recent Takeda/Shire deal. I am sharing the slides that I used there, where I am discussing about the facts and implications of the […]


Pricing rules in Japan; an awkward development

June 8, 2018 Tosh Nagate, CEO at e-Projection K.K. To make assumptions of the price of any product, from chocolate bars to computers, is one of the most daunting tasks for a product manager, but if it comes to drug pricing, the challenge is staggering. In many of the advanced economies, unlike any other product, […]


Conference Report

14th Annual Meeting of the Japanese Society of Medical Oncology July 28, 2016 Crizotinib vs Alectinib Miyako Satouchi Department of Thoracic oncology, Hyogo Cancer Center Program Came back to JSMO, this time in Kobe! Although most of the discussion is stemming from those fancy-looking immune checkpoint inhibitors, data from the so-called 2nd gen ALK inhibitors […]